| [1] |
Ambinder DI, Patil KD, Kadioglu H, et al. Pulseless electrical activity as the initial cardiac arrest rhythm: importance of preexisting left ventricular function[J].J Am Heart Assoc, 2021, 10(13): e018671.
|
| [2] |
Stangherlin A, Watson JL, Wong D, et al. Publisher correction: compensatory ion transport buffers daily protein rhythms to regulate osmotic balance and cellular physiology[J]. Nat Commun, 2021, 12(1):6988.
|
| [3] |
Tsai MS, Huang CH, Wang CH, et al. Post-cardiac arrest hydrocortisone use ameliorates cardiac mitochondrial injury in a male rat model of ventricular fibrillation cardiac arrest[J]. J Am Heart Assoc, 2021, 10(10):e019837.
|
| [4] |
Soares Sturzeneker MC, Montemezzo M, Precoma DB, et al. The relationship between non-alcoholic fatty liver disease and acute coronary syndrome severity: is non-alcoholic fatty liver disease a risk marker of coronary atherosclerotic disease?[J]. Eur Heart J, 2021, 42, ehab724.1449.
|
| [5] |
Young A, Garcia M, Sullivan SM, et al. Impaired peripheral microvascular function and risk of major adverse cardiovascular events in patients with coronary artery disease[J]. Arterioscler Thromb Vasc Biol, 2021, 41(5):1801-1809.
|
| [6] |
Yang JH, Choi KH, Ko YG, et al. Clinical characteristics and predictors of in-hospital mortality in patients with cardiogenic shock: results from the rescue registry[J]. Circ Heart Fail, 2021, 14(16): e008141.
|
| [7] |
Crea F. Percutaneous coronary interventions: more complex than fixing stenoses[J]. Eur Heart J, 2021, 42(45): 4607-4611.
|
| [8] |
Escaned J, Cao D, Baber U, et al. Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR[J]. Eur Heart J, 2021, 42(45): 4624-4634.
|
| [9] |
Tamaki Y, Yaku H, Morimoto T, et al. Lower in-hospital mortality with beta-blocker use at admission in patients with acute decompensated heart failure[J]. J Am Heart Assoc, 2021, 10(13): e020012.
|
| [10] |
Rossello X, Bueno H, Gil V, et al. Synergistic impact of systolic blood pressure and perfusion status on mortality in acute heart failure[J]. Circ Heart Fail, 2021, 14(3): e007347.
|
| [11] |
Mohammadalipour SH, Cascella A, Valentine M, et al. Enhancing the accuracy of cardiac rhythm analysis in automated external defibrillators during ongoing cardiopulmonary resuscitation by applying a deep encoder-decoder filtering model[J]. Circulation, 2021, 144: A12792-A12792.
|
| [12] |
Sharif ZI, Galand V, Hucker WJ,et al. Evolving cardiac electrical therapies for advanced heart failure patients[J]. Circ Arrhythm Electrophysiol, 2021, 14(4): e009668.
|
| [13] |
Borggrefe MM, Lawo T, Butter C, et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure[J]. Eur Heart J, 2008, 29(8):1019-1028.
|
| [14] |
Makimoto H, Shiraga T, Kohlmann B, et al. On-device artificial intelligence: mobile solution for detecting severe aortic valve stenosis based on heart sounds[J]. Eur Heart J, 2021, 42:ehab724.3053.
|
| [15] |
Schorr EN, Gepner AD, Dolansky MA, et al. Harnessing mobile health technology for secondary cardiovascular disease prevention in older adults: a scientific statement from the american heart association[J]. Circ Cardiovasc Qual Outcomes, 2021, 14(5): e000103.
|
| [16] |
Marvel FA, Spaulding EM, Lee MA, et al. Digital health intervention in acute myocardial infarction[J]. Circ Cardiovasc Qual Outcomes, 2021, 14(7): e007741.
|
| [17] |
Metkus TS, Sokoll LJ, Barth AS, et al. Myocardial injury in severe COVID-19 compared with non-COVID-19 acute respiratory distress syndrome[J]. Circulation. 2021; 143(6):553-565.
|
| [18] |
Rudski L, Januzzi JL, Rigolin VH, et al. Expert panel from the ACC cardiovascular imaging leadership council. multimodality imaging in evaluation of cardiovascular complications in patients with COVID-19: JACC scientific expert panel[J]. J Am Coll Cardiol, 2020, 76(11):1345-1357.
|
| [19] |
Ortuno JR, Pena ML, Haldon JE, et al. Utility of familial screening in non-syndromic thoracic aortic disease[J]. European Heart Journal, 2021, 42, ehab724.2016.
|
| [20] |
Chilazi M, Duffy EY, Thakkar A, et al. COVID and cardiovascular disease: what we know in 2021[J]. Curr Atheroscler Rep, 2021, 23(7):37.
|